Résumé
Chemotherapy of colorectal cancer has been dramatically modified during the last 10 years. Before the roles of oxaliplatin and irinotecan had been satisfactorily evaluated, targeted therapies appeared in the field of treatment for these patients. Numerous questions remain unanswered. However, recent data is helping to clarify matters concerning the day to day treatment of such patients. Clearly it is time to evaluate these recent studies and that is the aim of this article.
Titre traduit de la contribution | Developments in chemotherapy treatment of metastatic colorectal cancer |
---|---|
langue originale | Français |
Pages (de - à) | 169-174 |
Nombre de pages | 6 |
journal | Oncologie |
Volume | 10 |
Numéro de publication | 3 |
Les DOIs | |
état | Publié - 1 mars 2008 |
mots-clés
- Bevacizumab
- Cetuximab
- Chemotherapy
- Colorectal neoplasms
- Irinotecan
- Oxaliplatin
- Panitumumab
- Targeted therapies